Unleashing Innovation: The Case for Permissionless R&D in Pharma

A recent article in Communications of the ACM explores opportunities for “Permissionless innovation” in pharmaceuticals. “Permissionless innovation” refers to the freedom to explore new technologies or businesses without needing prior approval. It has fueled rapid innovation in the IT industry through open APIs, platforms, and ecosystem development. The main points are: The central premise is […] Source